Company
Kymera Therapeutics, Inc.
KYMR · CIK 0001815442
Sale of 1,209 shares at $115.55 per share.
Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →
Sale of 3,025 shares at $116.81 per share.
Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →
Sale of 2,137 shares at $117.57 per share.
Reporting Person Adams Brian · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001193125-26-383874 · filed 2026-09-04 · View filing →